Metware Biotechnology
MetwareBio is a US-based multi-omics CRO founded in 2015 that delivers mass spectrometry-based metabolomics, proteomics, lipidomics, spatial omics, and multi-omics integration services to academic, clinical, pharmaceutical, agricultural, and industrial research clients worldwide.
- Company typePrivate
- Founded2015
- HeadquartersWoburn, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Metware Biotechnology does
Metware Biotechnology (operating as MetwareBio) is a US-headquartered multi-omics Contract Research Organization founded in 2015 and based in Woburn, Massachusetts, with 251-500 employees. The company delivers fee-for-service analytical projects across metabolomics, proteomics, lipidomics, spatial omics, and integrated multi-omics to academic, clinical, pharmaceutical, agricultural, and industrial research clients, claiming more than 20,000 completed projects, 1,000,000+ samples processed annually, and contributions to over 1,000 peer-reviewed publications in journals including Cell, Nature, and Nature Metabolism.
The technical foundation rests on mass spectrometry instrumentation (LC-MS/MS, GC-MS, and Bruker timsTOF HT with TIMS+PASEF acquisition for proteomics) and proprietary data assets, most notably the Widely-Targeted Metabolomics Database (MWDB) of 280,000+ curated metabolites plus a 30,000+ plant-specific database. Service delivery is supported by the Metware Cloud Platform, a freemium environment offering 50+ analysis tools for differential analysis, functional enrichment, multi-omics association, and file conversion, and by standardized QC workflows spanning ten data quality indicators.
MetwareBio generates revenue through custom-priced, quote-based CRO projects sold directly via website consultation requests, conference engagements, and a formal client referral program. Pricing is project-dependent, varying by sample type, sample count, omics platform, and analytical depth. The company pursues a sales-led, vertical-segmented GTM motion targeting five distinct buyer segments, with academic research as the primary segment and no disclosed resellers or marketplace distribution. No funding rounds, ownership structure, or executive team data are disclosed in the available material, and certifications, patents, and partnership agreements are not represented.
Metware Biotechnology firmographics
Firmographics- Name
- Metware Biotechnology
- Legal name
- Metware Biotechnology Inc.
- Website
- https://metwarebio.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- MetwareBio is a US-based multi-omics CRO founded in 2015 that delivers mass spectrometry-based metabolomics, proteomics, lipidomics, spatial omics, and multi-omics integration services to academic, clinical, pharmaceutical, agricultural, and industrial research clients worldwide.
- Ownership category
- akta.pro rank
Metware Biotechnology industry classification
Industry- Product category
- Multi-omics Contract Research Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Metabolomics & Lipidomics Services (HLAGANAG)
- akta.pro secondary industry
- Proteomics & Mass Spectrometry Services (HLAGANAB)
Keywords
Where Metware Biotechnology is headquartered
LocationHeadquarters
- HQ city
- Woburn
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Metware Biotechnology business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Omics Research Services (CRO/Contract Research): MetwareBio generates revenue by providing fee-for-service multi-omics analytical services to academic, clinical, pharmaceutical, agricultural, and industrial research clients. Projects are custom-designed based on client consultation and typically priced per sample, per project, or as part of comprehensive study packages. Revenue is project-based and recurring through ongoing research partnerships and repeat client engagements.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Custom project-based pricing |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels8 records
Metware Biotechnology product offering
Product offeringCore offering
Metware Biotechnology (MetwareBio) is a multi-omics Contract Research Organization (CRO) that delivers fee-for-service proteomics, metabolomics, lipidomics, spatial omics, and integrated multi-omics analysis using high-resolution mass spectrometry platforms (LC-MS/MS, GC-MS, timsTOF HT). Projects are custom-designed in consultation with clients and supported by proprietary resources including the Widely-Targeted Metabolomics Database (MWDB, 280,000+ metabolites) and the Metware Cloud Platform for data analysis. The company serves academic, clinical, pharmaceutical, agricultural, and industrial research clients globally.
Product overview
MetwareBio is a multi-omics CRO (Contract Research Organization) offering integrated omics services spanning proteomics, metabolomics, lipidomics, spatial omics, and multi-omics integration. The portfolio includes targeted and untargeted metabolomics services (Global Metabolite Profiling, TM Widely-Targeted Metabolomics, Plant Metabolomics), comprehensive proteomics (DIA/DDA Quantitative, PTM Proteomics), lipidomics, spatial omics, and integrated multi-omics solutions (Proteomics+Metabolomics, Transcriptome+Metabolome, Microbiome+Metabolome). These services are supported by a proprietary Metabolite Database (MWDB) with 280,000+ metabolites and the Metware Cloud Platform for data analysis. The company operates mass spectrometry platforms including timsTOF HT with TIMS+PASEF technology for high-sensitivity proteomics and metabolomics detection.
Differentiator
Problem solved
Functional benefit
Products and services
- Metabolomics Services Comprehensive LC-MS and GC-MS based metabolomics services including untargeted metabolomics, widely-targeted metabolomics, and targeted metabolite panels for biomarker discovery and metabolic pathway analysis, targeted at academic, clinical, pharmaceutical, agricultural, and industrial researchers.
- Proteomics Services Mass spectrometry-based proteomics services including DIA and DDA quantitative proteomics, PTM proteomics (phosphorylation, ubiquitination, glycosylation, lactylation, succinylation, acetylation), and low-input proteomics for biomarker discovery and disease research, targeted at academic, clinical, and pharmaceutical researchers.
- Lipidomics Services LC-MS-based lipidomics services including quantitative lipidomics profiling, lipid class-specific analysis, and spatial lipidomics for studying lipid metabolism and disease associations, targeted at academic, clinical, and pharmaceutical researchers.
- Spatial Omics Services Spatial metabolomics and lipidomics services that map the spatial distribution of metabolites and lipids directly in tissue sections to reveal molecular localization, tissue heterogeneity, and microenvironment-related metabolic changes, targeted at researchers in cancer, neuroscience, and plant biology.
- Multi-Omics Integration Services Integrated multi-omics solutions combining proteomics, metabolomics, transcriptomics, and microbiome analysis including Proteomics+Metabolomics, Microbiome+Metabolome, Transcriptome+Metabolome, and Transcriptomics+Proteomics+Metabolomics integration, targeted at researchers seeking holistic biological insight.
- Metware Cloud Platform Cloud-based data analysis platform offering 50+ tools for omics data processing, statistical analysis (PCA, heatmap, violin plots), differential analysis, functional enrichment, multi-omics association analysis, gene sequence analysis, and file format conversion, available via free registration for researchers and analysts processing omics data.
- Targeted Metabolomics Panels Specialized targeted metabolomics panels including Energy Metabolism, One-Carbon Metabolism, Tryptophan Metabolism, Bile Acids, Steroid Hormones, Neurotransmitters, Oxylipins, Amino Acids, Free Fatty Acids, Short-Chain Fatty Acids, Sugars, Organic Acids, Plant Hormones, Carotenoids, Anthocyanins, and Gibberellins for specific metabolic pathway analysis, targeted at researchers needing focused pathway-level quantification.
- Plant Metabolomics Services Specialized plant metabolomics including Plant Widely-Targeted Metabolomics (2,500+ metabolites with 61K+ proprietary database), Flavonoid Analysis, Plant Hormone assays, and Plant Quantitative Lipidomics for crop breeding, stress biology, and natural product research, targeted at agricultural researchers and plant scientists.
- Metabolite Database (MWDB) Proprietary curated metabolite database containing 280,000+ metabolites and over 30,000 plant-specific primary and secondary metabolites, supporting widely-targeted metabolomics detection and identification across diverse biological samples, used internally and as a reference resource supporting MetwareBio's service offerings.
Companies that use Metware Biotechnology
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles5 records
Metware Biotechnology technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature6 records
Metware Biotechnology partnerships and signals
Strategic signalScale indicators12 records
Recent moves6 records
Expansion highlights6 records
Metware Biotechnology competitors and assessment
Company assessmentBroad incumbents
- SCIEX: SCIEX (a Danaher company) produces mass spectrometry instruments (including the ZenoTOF) commonly used in metabolomics and proteomics labs and offers application support and service programs, operating as a broad instrument-side incumbent overlapping MetwareBio's instrumentation stack.
- Eurofins Scientific: Eurofins is a large international testing CRO with significant omics and bioinformatics service offerings (e.g., Eurofins Genomics), competing with MetwareBio across metabolomics, proteomics, and genomic analyses for pharma and academic clients.
- Thermo Fisher Scientific: Thermo Fisher supplies Orbitrap mass spectrometers used widely in metabolomics and proteomics and offers its own proteomics/multi-omics services via PPD, serving as a broad incumbent across both instruments and CRO services overlapping MetwareBio.
- Bruker: Bruker manufactures the timsTOF mass spectrometry instruments MetwareBio uses and bundles proteomics applications and services (including via Biognosys historically), competing both as an instrument vendor and an omics-enabled services player.
Direct peers
- Novogene: Novogene is a global multi-omics services provider offering sequencing, proteomics, metabolomics, and multi-omics integration to academic and biopharma researchers, overlapping heavily with MetwareBio's integrated multi-omics portfolio.
- Olink: Olink provides proximity extension assay–based proteomics biomarker discovery services and panels, competing with MetwareBio's proteomics services in the pharma biomarker discovery market with a different technology platform.
- SomaLogic: SomaLogic operates the SomaScan proteomics platform for large-scale protein biomarker measurement, competing with MetwareBio's proteomics offerings for high-throughput translational and pharma biomarker discovery engagements.
- Biognosys: Biognosys is a proteomics CRO specializing in DIA mass spectrometry–based protein quantification (SpectroDive/PQI), directly competing with MetwareBio's DIA quantitative proteomics offering for biomarker discovery and pharma translational studies.
- Metabolon: Metabolon is a leading metabolomics CRO offering untargeted and targeted metabolite profiling services to pharma, academic, and clinical research clients — directly comparable to MetwareBio's metabolomics services and competing for similar biomarker discovery and translational research projects.
Regional players
- BGI Group: BGI is one of the world's largest genomics and multi-omics service providers, with strongest presence in Asia-Pacific, offering sequencing, proteomics, and metabolomics services that overlap with MetwareBio's integrated multi-omics portfolio in regional rather than head-to-head U.S. accounts.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Metware Biotechnology social profiles
Digital presenceMetware Biotechnology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Metware Biotechnology leadership team
Management profileNumber of profiles
Metware Biotechnology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Metware Biotechnology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Metware Biotechnology
What does Metware Biotechnology do?
Metware Biotechnology (MetwareBio) is a multi-omics Contract Research Organization (CRO) that delivers fee-for-service proteomics, metabolomics, lipidomics, spatial omics, and integrated multi-omics analysis using high-resolution mass spectrometry platforms (LC-MS/MS, GC-MS, timsTOF HT). Projects are custom-designed in consultation with clients and supported by proprietary resources including the Widely-Targeted Metabolomics Database (MWDB, 280,000+ metabolites) and the Metware Cloud Platform for data analysis. The company serves academic, clinical, pharmaceutical, agricultural, and industrial research clients globally.
Is Metware Biotechnology a public or private company?
Metware Biotechnology is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Metware Biotechnology founded?
Metware Biotechnology was founded in 2015. It employs 251 to 500 people.
Where is Metware Biotechnology based?
Metware Biotechnology is headquartered in Woburn, United States, in the North America region.
How does Metware Biotechnology make money?
One revenue line is on record: omics Research Services (CRO/Contract Research).
Who are Metware Biotechnology's main competitors?
Broad incumbents on record are SCIEX, Eurofins Scientific, Thermo Fisher Scientific and Bruker. Direct peers are Novogene, Olink, SomaLogic, Biognosys and Metabolon. BGI Group is listed as a regional player.
Does Metware Biotechnology have an API?
No public API is recorded for Metware Biotechnology.
What industry is Metware Biotechnology in?
Metware Biotechnology's product category is Multi-omics Contract Research Services. Its primary akta.pro industry code is HLAGANAG, Metabolomics & Lipidomics Services, with a secondary code of HLAGANAB, Proteomics & Mass Spectrometry Services. Its NAICS code is 5417 and its SIC code is 8731.